首页> ACS medicinal chemistry letters> BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder

导出原文传递

翻译打印收藏纠错

第一作者： Lawrence R. Marcin

作者： Lawrence R. Marcin ^[1] ; Jayakumar Warrier ^[2] ; Srinivasan Thangathirupathy ^[3] ; Jianliang Shi ; George N. Karageorge ; Bradley C. Pearce ; Alicia Ng ; Hyunsoo Park ; James Kempson ; Jianqing Li ; Huiping Zhang ; Arvind Mathur ; Aliphedi B. Reddy ; G. Nagaraju ; Gopikishan Tonukunuru ; Grandhi V. R.K. M. Gupta ; Manjunatha Kamble ; Raju Mannoori ; Srinivas Cheruku ; Srinivas Jogi ; Jyoti Gulia ; Tanmaya Bastia ; Charulatha Sanmathi ; Jayant Aher ; Rajareddy Kallem ; Bettadapura N. Srikumar ; Kumar Kuchibhotla Vijaya ; Pattipati S. Naidu ; Mahesh Paschapur ; Narasimharaju Kalidindi ; Reeba Vikramadithyan ; Manjunath Ramarao ; Rex Denton ; Thaddeus Molski ; Eric Shields ; Murali Subramanian ; Xiaoliang Zhuo ; Michelle Nophsker ; Jean Simmermacher ; Michael Sinz ; Charlie Albright ; Linda J. Bristow ; Imadul Islam ; Joanne J. Bronson ; Richard E. Olson ; Dalton King ; Lorin A. Thompson ; John E. Macor

作者单位： Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, Connecticut 06492, United States ^[1] Bristol-Myers Squibb Research and Development, 3551 Lawrenceville Road, Princeton, New Jersey 08648, United States ^[2] Biocon Bristol-Myers Squibb Research Center, Bangalore, India ^[3]

关键词 BMS-986163 BMS-986169 depression GluN2B ketamine negative allosteric modulator preclinical candidate

发布时间 2019-07-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交